simvastatin has been researched along with Adenocarcinoma in Situ in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eibl, G; Hines, OJ; Lugea, A; Pandol, SJ; Rozengurt, E; Sinnett-Smith, J; Sun, X; Teper, Y; Waldron, RT; Ye, L | 1 |
1 other study(ies) available for simvastatin and Adenocarcinoma in Situ
| Article | Year |
|---|---|
Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice.
Topics: Adenocarcinoma in Situ; Animals; Carcinoma, Pancreatic Ductal; Female; Male; Mice; Obesity; Pancreatic Neoplasms; Simvastatin | 2023 |